BA
Bobak R. Azamian
President/CEO and Board ChairDirector

Bobak R. Azamian insider trades: Tarsus Pharmaceuticals (TARS) stock sales

President/CEO and Board Chair, Tarsus Pharmaceuticals Last trade Sep 2, 2026 62 Form 4 filings
$1.4M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
53
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bobak reports to the SEC

Open-market buys and sales

53 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2026TARS↓ Sell$801K
Jun 17, 2026TARS↓ Sell$615K
Sep 24, 2025TARS↓ Sell$332K
Aug 11, 2025TARS↓ Sell$300K
Mar 24, 2025TARS↓ Sell$300K
Mar 20, 2025TARS↓ Sell$1.2M
Mar 18, 2024TARS↓ Sell$319K
Dec 27, 2023TARS↓ Sell$162K
Dec 20, 2023TARS↓ Sell$811K
Nov 15, 2023TARS↓ Sell$147K
Oct 18, 2023TARS↓ Sell$106K
Sep 20, 2023TARS↓ Sell$138K
Aug 23, 2023TARS↓ Sell$138K
Jul 19, 2023TARS↓ Sell$2.1M
Jul 12, 2023TARS↓ Sell$156K
Jun 21, 2023TARS↓ Sell$149K
Jun 14, 2023TARS↓ Sell$167K
Jun 8, 2023TARS↓ Sell$62K
May 17, 2023TARS↓ Sell$127K
May 10, 2023TARS↓ Sell$151K
May 1, 2023TARS↓ Sell$153K
Apr 21, 2023TARS↓ Sell$35K
Apr 19, 2023TARS↓ Sell$109K
Mar 23, 2023TARS↓ Sell$27K
Mar 20, 2023TARS↓ Sell$20K
Mar 16, 2023TARS↓ Sell$11K
Mar 15, 2023TARS↓ Sell$110K
Mar 9, 2023TARS↓ Sell$84K
Feb 15, 2023TARS↓ Sell$122K
Feb 8, 2023TARS↓ Sell$136K
Jan 23, 2023TARS↓ Sell$75K
Jan 20, 2023TARS↓ Sell$120K
Jan 11, 2023TARS↓ Sell$59K
Jan 10, 2023TARS↓ Sell$25K
Jan 6, 2023TARS↓ Sell$6K
Dec 21, 2022TARS↓ Sell$117K
Dec 16, 2022TARS↓ Sell$8K
Dec 14, 2022TARS↓ Sell$97K
Nov 16, 2022TARS↓ Sell$135K
Nov 9, 2022TARS↓ Sell$161K
Oct 19, 2022TARS↓ Sell$135K
Oct 12, 2022TARS↓ Sell$143K
Sep 21, 2022TARS↓ Sell$130K
Sep 14, 2022TARS↓ Sell$144K
Aug 17, 2022TARS↓ Sell$133K
Dec 1, 2021TARS↓ Sell$144K
Nov 1, 2021TARS↓ Sell$162K
Oct 12, 2021TARS↓ Sell$145K
Oct 8, 2021TARS↓ Sell$8K
Sep 1, 2021TARS↓ Sell$147K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TARS insiders

Open-market trades in the last 12 months

About Bobak R. Azamian's insider trades

Bobak R. Azamian is President/CEO and Board Chair at Tarsus Pharmaceuticals (TARS). Since Aug 5, 2021, Bobak has reported no open-market purchases and 53 sales worth $11.3M on SEC Form 4. In the last 12 months: 2 sales ($1.4M).

Their filings also include grants and awards (6 filings), option exercises (4 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TARS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.